Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study.
- DOI
- 10.1016/j.ejca.2026.116584
- Published
- 2026-02-16
- Container
- Eur J Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2026.116584,
title = {Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study.},
author = {Pedersen S and Colmorn LB and Ellebaek E and Kristensen SG and Ruhlmann C and Borch TH and Donia M and Fedder J and Macklon KT and Svane IM.},
year = {2026},
journal = {Eur J Cancer},
doi = {10.1016/j.ejca.2026.116584},
url = {https://doi.org/10.1016/j.ejca.2026.116584}
}RIS
TY - JOUR TI - Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study. AU - Pedersen S AU - Colmorn LB AU - Ellebaek E AU - Kristensen SG AU - Ruhlmann C AU - Borch TH AU - Donia M AU - Fedder J AU - Macklon KT AU - Svane IM. PY - 2026 JO - Eur J Cancer DO - 10.1016/j.ejca.2026.116584 UR - https://doi.org/10.1016/j.ejca.2026.116584 ER -
APA
S, P., LB, C., E, E., SG, K., C, R., TH, B., M, D., J, F., KT, M., & IM., S. (2026). Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study.. Eur J Cancer. https://doi.org/10.1016/j.ejca.2026.116584
Source records
- europe-pmc · retrieved 2026-09-26T11:13:56.285Z